AN2 Therapeutics develops new medicines to treat bacterial lung diseases and other infectious conditions using a specialized chemical platform. Their main drug candidate is currently being tested in late-stage clinical trials as a daily oral treatment. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
